Chronos Archive seal
The Human Record

Jane Austen

Case HR-EN014-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
December 16, 1775 – July 18, 1817
Synthetic DOB
1775-12-16
Index visit
1816-03-16 at age 40
Synthetic MRN
HR-EN014-SYN-TD

Teaching objective: Recognize primary adrenal insufficiency in a 40-year-old writer whose tiredness, weight loss, nausea, back ache and darkening skin could be put down to overwork or low mood, and care for it on the Endocrine Society 1806 guideline: low sodium, high potassium and raised eosinophils as clues; urgent testing with an 8 am cortisol and ACTH and a cosyntropin stimulation test, without delaying treatment if she becomes unstable; renin and aldosterone for mineralocorticoid deficiency; 21-hydroxylase antibodies for the cause, with adrenal imaging and tuberculosis testing only if they are negative; lymphoma kept in the differential (examination for nodes and spleen, LDH, chest X-ray, and weight and symptoms on treatment) because a retrospective diagnosis of her real illness proposes it; hydrocortisone in two daily doses and fludrocortisone adjusted by blood pressure lying and standing, electrolytes and renin; written sick-day rules, an emergency injection kit, a steroid card and a medical ID, then used in a febrile illness; screening for associated autoimmune disease; anemia work-up (CMID anemia monograph); and listening to the patient's own written account of her illness. Her real illness remains undiagnosed; this record shows one modern possibility, not an answer.

Historical timeline

DateEventClaims
December 16, 1775Born at Steventon Rectory, Hampshire.CLM-0001
1783Putrid fever at school in Southampton; nearly died.CLM-0004
January 21, 1805Death of her father after an illness of forty-eight hours.CLM-0020
1809Moved to Chawton with her mother and sister; neither sister married.CLM-0002, CLM-0003
March 1816Her health began to break.CLM-0005
May 1816Three weeks at Cheltenham; visibly out of health.CLM-0006
July 18, 1816First draft of Persuasion finished.CLM-0007
September 8, 1816Letter on back pain, agitation and fatigue.CLM-0008
February 20, 1817Letter on rheumatism.CLM-0009
March 23, 1817Letter on fever and her colour.CLM-0010
April 6, 1817Letter on a bilious attack with fever; confined upstairs; seen pale and weak by her niece.CLM-0011, CLM-0012
July 18, 1817Died at Winchester; buried in Winchester Cathedral.CLM-0013
1964Cope proposes Addison's disease.CLM-0015
2005Upfal proposes Hodgkin's disease.CLM-0016
2009White proposes disseminated bovine tuberculosis.CLM-0017
2017British Library post on cataracts and the arsenic theory.CLM-0019
2021Sanders and Graham propose systemic lupus erythematosus; the society biography gives Addison's disease as possible.CLM-0014, CLM-0018

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Jane Austen was born at the Rectory in Steventon, a village in north-east Hampshire, on 16 December 1775, the seventh child and second daughter of the rector, the Revd George Austen, and his wife Cassandra (née Leigh). confirmed Jane Austen: A brief biography supports
HISTMED Master Roster v3 context
D Steventon Rectory was her home for the first 25 years of her life; after some years in Bath and Southampton she moved in 1809 with her mother and sister to a cottage at Chawton, on one of her brother Edward's Hampshire estates, where she revised her early novels and wrote Mansfield Park, Emma and Persuasion.
Anchors the modern home and work history.
confirmed Jane Austen: A brief biography supports
D Her only sister, Cassandra, like Jane herself, never married.
Anchors the modern social history; she has no children.
confirmed Jane Austen: A brief biography supports
D In 1783, as a young child at school in Southampton with her sister, she caught a putrid fever and was very ill and nearly died.
Past history only; not used as a modern diagnosis.
probable Austen-Leigh W, Austen-Leigh RA. Jane Austen, Her Life and Letters: A Family Record (1913), Project Gutenberg eBook 22536 supports
D The chronology in the 1913 family biography dates the first break in her health to about March 1816.
The anchor for the index visit and the synthetic presenting illness.
probable Austen-Leigh W, Austen-Leigh RA. Jane Austen, Her Life and Letters: A Family Record (1913), Project Gutenberg eBook 22536 supports
D In May 1816 she and Cassandra spent three weeks at Cheltenham, stopping at Steventon and at Kintbury on the way; the family biographers judged that she 'must have been decidedly out of health, for the change in her did not escape the notice of her friends.'
After the index date. No modern visit is placed in May or June.
probable Austen-Leigh W, Austen-Leigh RA. Jane Austen, Her Life and Letters: A Family Record (1913), Project Gutenberg eBook 22536 supports
D She wrote 'Finis' at the end of the first draft of Persuasion on 18 July 1816; the family memoir quoted in the 1913 biography speaks of the weak state of her health at the time.
After the index date; recorded as history.
confirmed Austen-Leigh W, Austen-Leigh RA. Jane Austen, Her Life and Letters: A Family Record (1913), Project Gutenberg eBook 22536 supports
D In a letter to Cassandra on 8 September 1816 she wrote: 'Thank you, my back has given me scarcely any pain for many days. I have an idea that agitation does it as much harm as fatigue, and that I was ill at the time of your going from the very circumstance of your going.'
After the index date; her own account of back pain and fatigue, echoed in the synthetic presenting symptoms.
confirmed Austen-Leigh W, Austen-Leigh RA. Jane Austen, Her Life and Letters: A Family Record (1913), Project Gutenberg eBook 22536 supports
Coolidge S (ed.). The Letters of Jane Austen, selected from the Brabourne edition (1892), Project Gutenberg eBook 42078 supports
D On 20 February 1817 she wrote to her niece Fanny Knight that she was 'almost entirely cured of my rheumatism—just a little pain in my knee, now and then'.
After the index date; recorded as history.
confirmed Austen-Leigh W, Austen-Leigh RA. Jane Austen, Her Life and Letters: A Family Record (1913), Project Gutenberg eBook 22536 supports
D On 23 March 1817 she wrote to Fanny Knight: 'I certainly have not been well for many weeks, and about a week ago I was very poorly. I have had a good deal of fever at times, and indifferent nights; but I am considerably better now and am recovering my looks a little, which have been bad enough—black and white and every wrong colour.'
After the index date; her own description of her colour, on which the Addison's disease interpretation rests.
confirmed Austen-Leigh W, Austen-Leigh RA. Jane Austen, Her Life and Letters: A Family Record (1913), Project Gutenberg eBook 22536 supports
Coolidge S (ed.). The Letters of Jane Austen, selected from the Brabourne edition (1892), Project Gutenberg eBook 42078 supports
Sanders MD, Graham EM. 'Black and white and every wrong colour': the medical history of Jane Austen and the possibility of systemic lupus erythematosus. Lupus. 2021;30(6) (PMID 33596714) context
D On 6 April 1817 she wrote to her brother Charles that she had been 'suffering from a bilious attack attended with a good deal of fever', that she lived upstairs for the present, and that she was not strong enough to travel except in a closed carriage.
After the index date; recorded as history.
confirmed Austen-Leigh W, Austen-Leigh RA. Jane Austen, Her Life and Letters: A Family Record (1913), Project Gutenberg eBook 22536 supports
D Her niece Caroline, who saw her in the spring of 1817, recalled that she was very pale, her voice weak and low, with 'a general appearance of debility and suffering', and had been told that she never had much acute pain.
After the index date; recorded as history.
confirmed Austen-Leigh W, Austen-Leigh RA. Jane Austen, Her Life and Letters: A Family Record (1913), Project Gutenberg eBook 22536 supports
D On 24 May 1817 she moved to Winchester to be under the care of Mr. Lyford; she died there on 18 July 1817 at lodgings at No. 8 College Street, and was buried a few days later in the north aisle of Winchester Cathedral.
History only; not used in the modern episode.
confirmed Jane Austen: A brief biography supports
Austen-Leigh W, Austen-Leigh RA. Jane Austen, Her Life and Letters: A Family Record (1913), Project Gutenberg eBook 22536 supports
R The Jane Austen Society's biography says she fell ill in 1816, possibly with Addison's disease.
Retrospective interpretation; the modern episode makes this diagnosis as synthetic content, not as a claim about her.
possible Jane Austen: A brief biography supports
R In 1964 the surgeon Sir Zachary Cope proposed in the British Medical Journal that her final illness was Addison's disease, which in his time was usually tuberculous; he relied heavily on her description of her colouring.
Retrospective interpretation, disputed by later authors.
disputed Cope Z. Jane Austen's last illness. Br Med J. 1964;2(5402):182-183 (PMID 14150900, PMC1816080) supports
Upfal A. Jane Austen's lifelong health problems and final illness: new evidence points to a fatal Hodgkin's disease and excludes the widely accepted Addison's. Med Humanit. 2005;31(1):3-11 (PMID 23674643) supports
White KG. Jane Austen and Addison's disease: an unconvincing diagnosis. Med Humanit. 2009;35(2) (PMID 23674705) supports
R Annette Upfal argued in 2005 that the evidence tends to exclude Addison's disease and that her fatal illness was quite possibly Hodgkin's disease, a lymphoma, with an immune deficiency perhaps present by January 1813; she also noted that Cassandra destroyed letters containing medical detail and that the cause cannot now be established conclusively.
Retrospective interpretation; the reason the modern consultant keeps lymphoma in the differential until it is excluded.
disputed Upfal A. Jane Austen's lifelong health problems and final illness: new evidence points to a fatal Hodgkin's disease and excludes the widely accepted Addison's. Med Humanit. 2005;31(1):3-11 (PMID 23674643) supports
R Katherine White argued in 2009 that symptoms reported by Addison's patients of the period (mental confusion, generalised pain, weight loss and anorexia) are absent from her letters, so Addison's disease is unlikely, and that disseminated bovine tuberculosis would explain her symptoms coherently.
Retrospective interpretation; the reason tuberculosis is considered as a cause until the antibody result is known.
disputed White KG. Jane Austen and Addison's disease: an unconvincing diagnosis. Med Humanit. 2009;35(2) (PMID 23674705) supports
R Sanders and Graham argued in 2021 that the rheumatism, facial skin changes, fever and fluctuating symptoms in her letters fulfil current classification criteria for systemic lupus erythematosus.
Retrospective interpretation; not used in the modern episode.
possible Sanders MD, Graham EM. 'Black and white and every wrong colour': the medical history of Jane Austen and the possibility of systemic lupus erythematosus. Lupus. 2021;30(6) (PMID 33596714) supports
R A British Library curator noted in 2017 that her early death has been attributed to Addison's disease, cancer and tuberculosis, and that in 2011 a crime writer suggested arsenic poisoning on the basis of her facial pigmentation; the curator presented cataracts, possibly from arsenic, only as a theory raised by her spectacles.
Retrospective speculation; not used in the modern episode.
disputed Tuppen S. Did Jane Austen develop cataracts from arsenic poisoning? supports
D Her father died on 21 January 1805 after an illness of only forty-eight hours.
Family history; the cause is not recorded in the cited source.
confirmed Austen-Leigh W, Austen-Leigh RA. Jane Austen, Her Life and Letters: A Family Record (1913), Project Gutenberg eBook 22536 supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S About three months of increasing tiredness, loss of 5 kg, darkening of the skin, nausea with bouts of vomiting, low back ache, salt craving and lightheadedness on standing, with low sodium, high potassium and raised eosinophils; adrenal insufficiency suspected and urgent endocrinology testing booked resolved confirmed active CLM-0005
S Primary adrenal insufficiency (Addison's disease): no cortisol response to cosyntropin with a markedly raised ACTH, and mineralocorticoid deficiency with raised renin and low aldosterone; on hydrocortisone and fludrocortisone; synthetic modern diagnosis chosen for a historical illness whose cause is disputed active confirmed both_with_link CLM-0014, CLM-0015
S Mild normocytic anemia (hemoglobin 11.4 g/dL) with normal ferritin, vitamin B12 and folate resolved confirmed active
S Group A streptococcal pharyngitis with fever, treated with amoxicillin and doubled hydrocortisone under the sick-day rules; resolved resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 1816-03-16 Hemoglobin [Mass/volume] in Blood 11.4 g/dL (low)
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1816-03-16 MCV [Entitic mean volume] in Red Blood Cells by Automated count 89 fL
Reference 80-100 fL
http://loinc.org · 787-2
S 1816-03-16 Leukocytes [#/volume] in Blood by Automated count 5.8 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1816-03-16 Eosinophils [#/volume] in Blood 0.74 10*3/uL (high)
Reference 0-0.5 10*3/uL
http://loinc.org · 26449-9
S 1816-03-16 Platelets [#/volume] in Blood by Automated count 262 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1816-03-16 Sodium [Moles/volume] in Serum or Plasma 131 mmol/L (low)
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1816-03-16 Potassium [Moles/volume] in Serum or Plasma 5.4 mmol/L (high)
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1816-03-16 Chloride [Moles/volume] in Serum or Plasma 99 mmol/L
Reference 98-107 mmol/L
http://loinc.org · 2075-0
S 1816-03-16 Carbon dioxide, total [Moles/volume] in Serum or Plasma 21 mmol/L (low)
Reference 22-29 mmol/L
http://loinc.org · 2028-9
S 1816-03-16 Urea nitrogen [Mass/volume] in Serum or Plasma 23 mg/dL (high)
Reference 7-20 mg/dL
http://loinc.org · 3094-0
S 1816-03-16 Creatinine [Mass/volume] in Serum or Plasma 0.94 mg/dL
Reference 0.57-1 mg/dL
http://loinc.org · 2160-0
S 1816-03-16 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1811)/1.73 sq M 79 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1816-03-16 Glucose [Mass/volume] in Serum or Plasma 72 mg/dL
Reference 70-139 mg/dL
http://loinc.org · 2345-7
S 1816-03-16 Calcium [Mass/volume] in Serum or Plasma 10.1 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 1816-03-16 Thyrotropin [Units/volume] in Serum or Plasma 3.6 mIU/L
Reference 0.45-4.5 mIU/L
http://loinc.org · 3016-3
S 1816-03-16 Thyroxine (T4) free [Mass/volume] in Serum or Plasma 1.1 ng/dL
Reference 0.8-1.8 ng/dL
http://loinc.org · 3024-7
S 1816-03-16 Ferritin [Mass/volume] in Serum or Plasma 64 ng/mL
Reference 15-150 ng/mL
http://loinc.org · 2276-4
S 1816-03-16 Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 486 pg/mL
Reference 232-1245 pg/mL
http://loinc.org · 2132-9
S 1816-03-16 Folate [Mass/volume] in Serum or Plasma 11.2 ng/mL
Reference Above 5.9 ng/mL: normal
http://loinc.org · 2284-8
S 1816-03-16 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 http://loinc.org · 44261-6
S 1816-03-19 Cortisol [Mass/volume] in Serum or Plasma 2.6 ug/dL (low)
Reference 8 am: 5 to 23 ug/dL
http://loinc.org · 2143-6
S 1816-03-19 Corticotropin [Mass/volume] in Plasma 548 pg/mL (high)
Reference 7.2-63 pg/mL
http://loinc.org · 2141-0
S 1816-03-19 Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IV rapid 3.4 ug/dL (low)
Reference Peak of 18 ug/dL or more excludes adrenal insufficiency (about 14 to 15 ug/dL on newer assays)
http://loinc.org · 1417-5
S 1816-03-19 Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IV rapid 3.9 ug/dL (low)
Reference Peak of 18 ug/dL or more excludes adrenal insufficiency (about 14 to 15 ug/dL on newer assays)
http://loinc.org · 1402-7
S 1816-03-19 Renin [Enzymatic activity/volume] in Plasma 16.2 ng/mL/h (high)
Reference Upright, mid-morning: 0.6 to 4.3 ng/mL/h
http://loinc.org · 2915-7
S 1816-03-19 Aldosterone [Mass/volume] in Serum or Plasma 1.8 ng/dL (low)
Reference Upright, mid-morning: 4 to 31 ng/dL
http://loinc.org · 1763-2
S 1816-03-19 Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma 172 U/L
Reference 140-280 U/L
http://loinc.org · 2532-0
S 1816-03-19 Sodium [Moles/volume] in Serum or Plasma 132 mmol/L (low)
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1816-03-19 Potassium [Moles/volume] in Serum or Plasma 5.3 mmol/L (high)
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1816-04-02 Sodium [Moles/volume] in Serum or Plasma 137 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1816-04-02 Potassium [Moles/volume] in Serum or Plasma 4.6 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1816-04-02 Creatinine [Mass/volume] in Serum or Plasma 0.86 mg/dL
Reference 0.57-1 mg/dL
http://loinc.org · 2160-0
S 1816-04-02 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1811)/1.73 sq M 88 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1816-04-02 Glucose [Mass/volume] in Serum or Plasma 88 mg/dL
Reference 70-139 mg/dL
http://loinc.org · 2345-7
S 1816-04-02 Hemoglobin [Mass/volume] in Blood 11.9 g/dL (low)
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1816-04-02 Eosinophils [#/volume] in Blood 0.38 10*3/uL
Reference 0-0.5 10*3/uL
http://loinc.org · 26449-9
S 1816-04-30 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1816-04-30 Potassium [Moles/volume] in Serum or Plasma 4.4 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1816-04-30 Creatinine [Mass/volume] in Serum or Plasma 0.84 mg/dL
Reference 0.57-1 mg/dL
http://loinc.org · 2160-0
S 1816-04-30 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1811)/1.73 sq M 90 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1816-04-30 Renin [Enzymatic activity/volume] in Plasma 3.4 ng/mL/h
Reference Upright, mid-morning: 0.6 to 4.3 ng/mL/h
http://loinc.org · 2915-7
S 1816-04-30 Hemoglobin [Mass/volume] in Blood 12.6 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1816-04-30 MCV [Entitic mean volume] in Red Blood Cells by Automated count 90 fL
Reference 80-100 fL
http://loinc.org · 787-2
S 1816-10-12 Sodium [Moles/volume] in Serum or Plasma 140 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1816-10-12 Potassium [Moles/volume] in Serum or Plasma 4.2 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1816-10-12 Creatinine [Mass/volume] in Serum or Plasma 0.85 mg/dL
Reference 0.57-1 mg/dL
http://loinc.org · 2160-0
S 1816-10-12 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1811)/1.73 sq M 89 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1816-10-12 Renin [Enzymatic activity/volume] in Plasma 2.8 ng/mL/h
Reference Upright, mid-morning: 0.6 to 4.3 ng/mL/h
http://loinc.org · 2915-7
S 1816-10-12 Hemoglobin [Mass/volume] in Blood 13.2 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 1816-10-12 Thyrotropin [Units/volume] in Serum or Plasma 2.9 mIU/L
Reference 0.45-4.5 mIU/L
http://loinc.org · 3016-3
S 1816-10-12 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 http://loinc.org · 44261-6
S 1816-04-20 Sodium [Moles/volume] in Serum or Plasma 136 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1816-04-20 Potassium [Moles/volume] in Serum or Plasma 4.7 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1816-04-20 Glucose [Mass/volume] in Serum or Plasma 91 mg/dL
Reference 70-139 mg/dL
http://loinc.org · 2345-7
S 1816-07-27 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 1816-07-27 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 2 http://loinc.org · 70274-6
S 1816-07-27 Total score [AUDIT-C] 1 http://loinc.org · 75626-2
S 1816-07-27 Cholesterol [Mass/volume] in Serum or Plasma 182 mg/dL
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 1816-07-27 Cholesterol in HDL [Mass/volume] in Serum or Plasma 68 mg/dL
Reference >=50 mg/dL
http://loinc.org · 2085-9
S 1816-07-27 Triglyceride [Mass/volume] in Serum or Plasma 74 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 1816-07-27 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 99 mg/dL
Reference <=99 mg/dL
http://loinc.org · 13457-7
S 1816-04-02 21-Hydroxylase Ab [Units/volume] in Serum 24 U/mL (high)
Reference Below 1 U/mL: negative
http://loinc.org · 17781-6
S 1816-04-02 Hemoglobin A1c/Hemoglobin.total in Blood 5%
Reference Below 5.7% is normal; 5.7 to 6.4% prediabetes
http://loinc.org · 4548-4
S 1816-04-02 Tissue transglutaminase IgA Ab [Units/volume] in Serum 0.8 U/mL
Reference Below 4 U/mL: negative
http://loinc.org · 31017-7
S 1816-04-02 IgA [Mass/volume] in Serum or Plasma 188 mg/dL
Reference 70-400 mg/dL
http://loinc.org · 2458-8

Synthetic vital signs

DateMeasureResultLOINCGrade
1816-03-16Body height170 cm8302-2S
1816-03-16Body weight52 kg29463-7S
1816-03-16Body mass index (BMI) [Ratio]18 kg/m239156-5S
1816-03-16Systolic blood pressure98 mm[Hg]8480-6S
1816-03-16Diastolic blood pressure62 mm[Hg]8462-4S
1816-03-16Heart rate92 /min8867-4S
1816-03-16Respiratory rate16 /min9279-1S
1816-03-16Body temperature37.4 Cel8310-5S
1816-03-16Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1816-03-19Body height170 cm8302-2S
1816-03-19Body weight51.8 kg29463-7S
1816-03-19Body mass index (BMI) [Ratio]17.9 kg/m239156-5S
1816-03-19Systolic blood pressure96 mm[Hg]8480-6S
1816-03-19Diastolic blood pressure60 mm[Hg]8462-4S
1816-03-19Heart rate94 /min8867-4S
1816-03-19Respiratory rate16 /min9279-1S
1816-03-19Body temperature37.3 Cel8310-5S
1816-03-19Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1816-04-02Body height170 cm8302-2S
1816-04-02Body weight53.4 kg29463-7S
1816-04-02Body mass index (BMI) [Ratio]18.5 kg/m239156-5S
1816-04-02Systolic blood pressure108 mm[Hg]8480-6S
1816-04-02Diastolic blood pressure68 mm[Hg]8462-4S
1816-04-02Heart rate80 /min8867-4S
1816-04-02Respiratory rate14 /min9279-1S
1816-04-02Body temperature36.8 Cel8310-5S
1816-04-02Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1816-04-30Body height170 cm8302-2S
1816-04-30Body weight55.2 kg29463-7S
1816-04-30Body mass index (BMI) [Ratio]19.1 kg/m239156-5S
1816-04-30Systolic blood pressure112 mm[Hg]8480-6S
1816-04-30Diastolic blood pressure72 mm[Hg]8462-4S
1816-04-30Heart rate74 /min8867-4S
1816-04-30Respiratory rate14 /min9279-1S
1816-04-30Body temperature36.7 Cel8310-5S
1816-04-30Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1816-10-12Body height170 cm8302-2S
1816-10-12Body weight57.2 kg29463-7S
1816-10-12Body mass index (BMI) [Ratio]19.8 kg/m239156-5S
1816-10-12Systolic blood pressure116 mm[Hg]8480-6S
1816-10-12Diastolic blood pressure74 mm[Hg]8462-4S
1816-10-12Heart rate68 /min8867-4S
1816-10-12Respiratory rate14 /min9279-1S
1816-10-12Body temperature36.6 Cel8310-5S
1816-10-12Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1816-04-20Body height170 cm8302-2S
1816-04-20Body weight53.6 kg29463-7S
1816-04-20Body mass index (BMI) [Ratio]18.5 kg/m239156-5S
1816-04-20Systolic blood pressure104 mm[Hg]8480-6S
1816-04-20Diastolic blood pressure64 mm[Hg]8462-4S
1816-04-20Heart rate98 /min8867-4S
1816-04-20Respiratory rate16 /min9279-1S
1816-04-20Body temperature38.4 Cel8310-5S
1816-04-20Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1816-07-27Body height170 cm8302-2S
1816-07-27Body weight56.6 kg29463-7S
1816-07-27Body mass index (BMI) [Ratio]19.6 kg/m239156-5S
1816-07-27Systolic blood pressure114 mm[Hg]8480-6S
1816-07-27Diastolic blood pressure72 mm[Hg]8462-4S
1816-07-27Heart rate70 /min8867-4S
1816-07-27Respiratory rate14 /min9279-1S
1816-07-27Body temperature36.6 Cel8310-5S
1816-07-27Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

Care-plan goals

GoalTarget dateStatusOutcome
A diagnosis within one week of the first visit, with treatment started the same day if adrenal insufficiency is confirmed1816-03-19completedCosyntropin test three days after the first visit; replacement started the same day
No adrenal crisis and no emergency admission through the episode1816-10-12completedNo crisis or admission; one febrile illness managed at home with stress dosing
Sodium and potassium normal, renin in the upper normal range, and no postural drop by the six-week visit1816-04-30completedSodium 139 and potassium 4.4 mmol/L; renin 3.4 ng/mL/h; no postural drop
She can state the sick-day rules and give the emergency injection by the two-week visit1816-04-02completedStated the rules and gave a practice injection on a trainer
Weight back to her usual 57 kg, and energy for full mornings of writing, by six months1816-10-12completedWeight 57.2 kg from 52.0; writing full mornings and walking several miles

Interventions

InterventionStatusGuideline
Initial evaluation of tiredness, weight loss, darkening skin, low sodium and high potassium: blood count, metabolic panel, thyroid tests, ferritin, vitamin B12 and folate at the first visit; urgent 8 am cortisol and ACTH with a cosyntropin stimulation test within days; until then, salt freely, and go to the emergency department at once for vomiting, fainting, confusion or severe abdominal paincompletedGL-ES-PAI-2016, GL-CMID-2026
Urgent endocrinology consultation within three days to confirm or exclude primary adrenal insufficiency, start replacement if confirmed, and plan the search for the causecompletedGL-ES-PAI-2016
Replacement: hydrocortisone 10 mg on waking and 5 mg at 2 pm (15 mg a day) and fludrocortisone 0.1 mg each morning, adjusted by weight, energy, blood pressure lying and standing, salt craving and signs of over- or under-replacement, with sodium, potassium and plasma renin after any fludrocortisone change and at least yearlycompletedGL-ES-PAI-2016
Written sick-day rules (double the hydrocortisone for fever above 38 °C, triple it above 39 °C, and inject 100 mg and call 911 for vomiting, inability to take tablets, or feeling faint), an emergency hydrocortisone injection kit with training, a steroid emergency card and a medical ID, reviewed at every visitcompletedGL-ES-PAI-2016
Cause and differential: 21-hydroxylase antibodies at the two-week visit; adrenal CT and tuberculosis testing only if they are negative; examination for lymph nodes and spleen, LDH and a chest X-ray now, with CT of the chest, abdomen and pelvis if weight loss, fevers, night sweats or enlarged nodes persist once replacement is establishedcompletedGL-ES-PAI-2016
Screening for associated autoimmune disease: TSH (normal at intake) at least yearly; vitamin B12, A1c, and celiac serology with total IgA; ask about periods at each visit and check FSH if they become irregular or stopcompletedGL-ES-PAI-2016, GL-ACG-CD-2023
Anemia: ferritin, vitamin B12 and folate at intake; repeat the blood count on treatment and look further only if it does not recovercompletedGL-CMID-2026
Streptococcal pharyngitis: amoxicillin 500 mg twice daily for ten days; hydrocortisone doubled under the sick-day rules until a day without fever and then back to the usual dose; fluids with salt; the emergency injection with a 911 call if she vomits or cannot take tablets; neck nodes rechecked at the six-week visitcompletedGL-ES-PAI-2016, GL-IDSA-GAS-2012

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Jane Austen: A brief biography The Jane Austen Society (UK) biography
SRC-0002 Austen-Leigh W, Austen-Leigh RA. Jane Austen, Her Life and Letters: A Family Record (1913), Project Gutenberg eBook 22536 Project Gutenberg biography
SRC-0003 Cope Z. Jane Austen's last illness. Br Med J. 1964;2(5402):182-183 (PMID 14150900, PMC1816080) British Medical Journal scholarly
SRC-0004 Upfal A. Jane Austen's lifelong health problems and final illness: new evidence points to a fatal Hodgkin's disease and excludes the widely accepted Addison's. Med Humanit. 2005;31(1):3-11 (PMID 23674643) Medical Humanities (BMJ) scholarly
SRC-0005 White KG. Jane Austen and Addison's disease: an unconvincing diagnosis. Med Humanit. 2009;35(2) (PMID 23674705) Medical Humanities (BMJ) scholarly
SRC-0006 Sanders MD, Graham EM. 'Black and white and every wrong colour': the medical history of Jane Austen and the possibility of systemic lupus erythematosus. Lupus. 2021;30(6) (PMID 33596714) Lupus (SAGE) scholarly
SRC-0007 Tuppen S. Did Jane Austen develop cataracts from arsenic poisoning? British Library other
SRC-0008 Coolidge S (ed.). The Letters of Jane Austen, selected from the Brabourne edition (1892), Project Gutenberg eBook 42078 Project Gutenberg other
SRC-0009 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the three-day interval to the cosyntropin test in a stable outpatient, the hydrocortisone and fludrocortisone doses, the sick-day rules, and how lymphoma and tuberculosis are kept in and then out of the differential.
provenance reviewnot_startedThe Jane Austen Society biography, the 1913 Family Record and the 1892 letters (Project Gutenberg), the British Library blog, and four PubMed records (three abstracts read) logged. Cope's 1964 article could not be read and is described through the Upfal and White abstracts. Le Faye's edition of the letters was not consulted.
safe messaging reviewnot_startedNo sensitive claims. Her death is recorded as history in one sentence. The modern diagnosis is presented as one possibility, not as the cause of her real illness.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.